Parabilis Medicines, Inc. (PBLS) stock
PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.25−0.20 (-0.70%)
Close on Nov 17, 2026Market cap $3.49BP/E –Yield –
Parabilis Medicines enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Parabilis Medicines's enterprise value was $2.50B on Nov 11, 2026.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.50B | – |
See a number that looks wrong?